These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24502684)

  • 1. An investigation of normal urine with a creatinine concentration under the cutoff of 20 mg/dL for specimen validity testing in a toxicology laboratory.
    Holden B; Guice EA
    J Forensic Sci; 2014 May; 59(3):806-10. PubMed ID: 24502684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of lowering the screening and confirmation cutoff values for urine drug testing based on dilution indicators.
    Fraser AD; Zamecnik J
    Ther Drug Monit; 2003 Dec; 25(6):723-7. PubMed ID: 14639059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creatinine in urine - a method comparison.
    Luginbühl M; Weinmann W
    Drug Test Anal; 2017 Oct; 9(10):1537-1541. PubMed ID: 28102586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Workplace drug testing on urine samples: evidence for improving efficacy of a first-level screening programme.
    Crespi V; Maio RC; Veronesi G; Gianfagna F; Taborelli S; Ferrario MM
    Med Lav; 2015 Sep; 106(5):374-85. PubMed ID: 26384263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine-creatinine concentration as a marker of urine dilution: reflections using a cohort of 45,000 samples.
    Arndt T
    Forensic Sci Int; 2009 Apr; 186(1-3):48-51. PubMed ID: 19216038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of creatinine reference value: Normalization of urinary drug concentrations.
    Aydoğdu M; Oral S; Akgür SA
    J Forensic Sci; 2021 Sep; 66(5):1855-1861. PubMed ID: 33904587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Creatinine concentration in urine should be measured in drug testing. Guidelines for decision limits and interpretation are necessary--at any rate for legal rights].
    Helander A; Ohlson M; Beck O; Hansson T; Kugelberg FC; Kronstrand R
    Lakartidningen; 2011 Jun 15-28; 108(24-25):1311-4. PubMed ID: 21830503
    [No Abstract]   [Full Text] [Related]  

  • 8. Verifying the validity of creatinine measurement in low-concentrated urine spot samples-Photospectrometry versus liquid chromatography-tandem mass spectrometry.
    Franz S; Skopp G; Dame T; Musshoff F
    Drug Test Anal; 2021 Jun; 13(6):1136-1144. PubMed ID: 33458951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine Creatinine Concentrations in Drug Monitoring Participants and Hospitalized Patients.
    Love SA; Seegmiller JC; Kloss J; Apple FS
    J Anal Toxicol; 2016 Oct; 40(8):659-662. PubMed ID: 27590035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations.
    Bush DM
    Forensic Sci Int; 2008 Jan; 174(2-3):111-9. PubMed ID: 17434274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The characterization of human urine for specimen validity determination in workplace drug testing: a review.
    Cook JD; Caplan YH; LoDico CP; Bush DM
    J Anal Toxicol; 2000 Oct; 24(7):579-88. PubMed ID: 11043663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiating new marijuana use from residual drug excretion in occasional marijuana users.
    Huestis MA; Cone EJ
    J Anal Toxicol; 1998 Oct; 22(6):445-54. PubMed ID: 9788519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creatinine normalization of workplace urine drug tests: does it make a difference?
    Price JW
    J Addict Med; 2013; 7(2):129-32. PubMed ID: 23370934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creatinine analysis in single collection urine specimens.
    Needleman SB; Porvaznik M; Ander D
    J Forensic Sci; 1992 Jul; 37(4):1125-33. PubMed ID: 1506830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation into the extent of possible dilution of specimens received for urinary drugs of abuse screening.
    George S; Braithwaite RA
    Addiction; 1995 Jul; 90(7):967-70. PubMed ID: 7663318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of fluid load on human urine characteristics related to workplace drug testing.
    Chaturvedi AK; Sershon JL; Craft KJ; Cardona PS; Soper JW; Canfield DV; Dubowski KM; Whinnery JE; Leyva MJ; Aston CE; Blevins SM; Wright JE; Fraser AD; Kuntz DJ
    J Anal Toxicol; 2013; 37(1):5-10. PubMed ID: 23104711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of freezing point depression osmolality for classifying random urine specimens defined as substituted under HHS/DOT criteria.
    Cook JD; Hannon MW; Vo T; Caplan YH
    J Anal Toxicol; 2002 Oct; 26(7):424-9. PubMed ID: 12422996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creatinine excretion in consecutive urine samples after controlled ingestion of water.
    Franz S; Skopp G; Boettcher M; Musshoff F
    Drug Test Anal; 2019 Mar; 11(3):435-440. PubMed ID: 30276981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine specimen validity test for drug abuse testing in workplace and court settings.
    Lin SY; Lee HH; Lee JF; Chen BH
    J Food Drug Anal; 2018 Jan; 26(1):380-384. PubMed ID: 29389577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.